The label-free detection of the antibiotic vancomycin binding to mucopeptides on cantilever arrays, with 10 nM sensitivity and at clinically relevant concentrations in blood serum, could lead to ...

The addition of vancomycin to beta-lactam prophylaxis in ... trial product was purchased removed the commercial labels and placed a sheath over the vial. Placebo consisted of matching empty ...

Even though the FDA has not approved daptomycin for the treatment of infection with vancomycin-resistant enterococci, clinicians often use it off-label in patients with severe enterococcal ...

Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures.

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...

Vancomycin always has been a problematic agent for treating patients with Staphylococcus infections because of its poor tissue penetration and slow bactericidal activity. In recent years, its use ...

Study: Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures.

By Tarun Sai Lomte A four-week treatment with oral vancomycin led to clinical remission in PSC-IBD patients, accompanied by significant shifts in gut microbiota, reduced inflammation, and altered ...

The results of this study revealed that implementation of a vancomycin nomogram into a CPOE system was associated with an increased percentage of patients with an initial optimal vancomycin ...

Vancomycin is the drug of choice for treating cellulitis, study suggests Date: October 28, 2010 Source: Henry Ford Health System Summary: Patients admitted to the hospital for the common bacterial ...